Client News

Boston Solar (CBOE: SING) Advances Sustainable Future with Boston Charter School

Woburn, Massachusetts–(Newsfile Corp. – May 1, 2024) – SinglePoint Inc (CBOE: SING) (“SinglePoint” or “the Company”) subsidiary Boston Solar, a proud partner of the Boston Red Sox and a leading provider of solar energy solutions, is pleased to announce the progression of its partnership with a Boston charter school, bringing sustainable energy solutions to the […]

Nuvve (Nasdaq: NVVE) and Great Power Announce Strategic Partnership to Accelerate Electric Vehicle Integration and Renewable Energy Adoption

SAN DIEGO and GUANGZHOU, China, April 30, 2024 /PRNewswire/ — Nuvve Holding Corp. (“Nuvve”) (Nasdaq: NVVE), a global technology leader accelerating the electrification of transportation through its proprietary energy management and aggregation platform, and  Guangzhou Great Power Energy and Technology Corporation (“Great Power)” (NCY: 300438.SZ), a global leader in lithium-ion battery manufacturing and research and development, are pleased to announce a […]

Mawson Infrastructure Group (NASDAQ: MIGI) Announces Expansion Plans at Midland, Pennsylvania Facilities

Plans to Expand Midland Facilities Capacity to 120 MW and Miner Capacity to 38,810 Miners Mawson’s Total Capacity Expected to be approximately 129 MW and 41,530 miners upon Expansion MIDLAND, Pa., April 30, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson”), a digital infrastructure company, today announced plans for expansion of the […]

American Rebel (NASDAQ: AREB) Receives License to Distribute American Rebel Beer in the State of Tennessee

Nashville, TN, April 30, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of American Rebel Beer (www.americanrebelbeer.com) and branded safes, personal security and self-defense products and apparel, is proud to announce their receipt of a license to distribute beer within the state of […]

Laser Photonics (NASDAQ: LASE) Unveils New Compact CleanTech CR-3030 Laser Cleaning System

ORLANDO, Fla., April 30, 2024–(BUSINESS WIRE)–Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global industrial developer of laser systems for laser cleaning and other material applications, unveiled its new small form factor CleanTech Commercial Roughening Laser 3030 (CleanTech CR-3030) for cleaning, roughening and surface preparation. The CleanTech CR-3030 is the world’s most compact and portable Class IV […]

Skye Bioscience (Nasdaq: SKYE) to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announced that it will present two posters at the Association for Research in Vision and Ophthalmology (ARVO) 2024 […]

Amesite (NASDAQ: AMST) Launches AI and Technical Training Programs with Volunteer State Community College

Online Learning Company Closes Another 5 Year Partnership with College in High Growth Region DETROIT, April 30, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced today the launch of non-degree AI and technical training programs for industry certification and […]

OKYO Pharma (NASDAQ: OKYO) Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA […]

NanoViricides (NYSE Amer:NNVC) Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon

SHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer:NNVC) (the “Company”), a global leader in broad-spectrum antiviral nanomedicines, reports that the Phase I Clinical Trial of NV-387 is completed successfully and data lock is expected soon. The Phase 1 clinical trial, protocol number KM-NVCoV2-001, which received approval from the regulatory agency in […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.